The practical problem of the oral glucose tolerance test is that it is time-consuming and difficult to accommodate within the primary-care setting, where most of the diagnoses of type 2 diabetes ...
Research investigating testing methods for gestational diabetes suggests that over half of pregnant women with the condition are not being diagnosed with the current NHS blood test process, leading to ...
Data from 593 participants with normal baseline glucose levels and 317 participants with impaired baseline glucose levels were analyzed separately. Of the 910 participants, 97 never drank coffee ...
Sitagliptin (Januvia™) is a new oral agent approved by the US FDA to treat Type 2 diabetes. This is the first approved agent in a new class of antihyperglycemics, dipeptidyl peptidase (DPP)-4 ...